» Articles » PMID: 24953203

Development and Validation of the Mayo Clinic Bowel Prep Tolerability Questionnaire

Overview
Journal Dig Liver Dis
Publisher Elsevier
Specialty Gastroenterology
Date 2014 Jun 24
PMID 24953203
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Bowel cleansing is paramount for colonoscopy quality. Unfortunately, an adequate bowel preparation is often limited by side effects and/or patient's intolerance to bowel preparation solutions. Comparisons among different preparations are limited by the lack of validated instruments designed to assess patient's tolerability.

Aim: To develop and validate a simple, comprehensive instrument to assess bowel preparation tolerability in patients undergoing colonoscopy.

Methods: Development and validation by phases: Phase I (bibliographic search and questionnaire design); Phase II (assessment of content validity and modification of the questionnaire); Phase III (assessment of reproducibility, final validation, and definitive version of the questionnaire).

Results: The initial draft of the questionnaire was generated based on a systematic literature review and feedback from a panel of consultants. Content validity was tested in a focus group of 25 patients undergoing colonoscopy. Patients' suggestions were reviewed by the research team and a second draft of the questionnaire was generated. Final validation and reproducibility were successfully tested (agreement: 86-100%, kappa: 0.77-1.00) in a convenience sample of 100 patients undergoing bowel preparation with different cleansing solutions.

Conclusion: The Mayo Clinic Bowel Prep Tolerability Questionnaire is a simple, comprehensive instrument suitable to evaluate the tolerability of various types of bowel preparations.

Citing Articles

Prospective, randomized study comparing two different regimens of split-dose polyethylene glycol and their effect on endoscopic outcomes.

Abou Zeid J, Hallit S, Akiki B, Abou Zeid Z, Yazbeck C BMC Gastroenterol. 2024; 24(1):132.

PMID: 38609900 PMC: 11010337. DOI: 10.1186/s12876-024-03212-z.


Safety and efficacy of sodium picosulfate, magnesium oxide, and citric acid bowel preparation in patients with baseline renal impairment or diabetes: subanalysis of a randomized, controlled trial.

Mankaney G, Ando M, Dahdal D, Burke C Therap Adv Gastroenterol. 2021; 14:17562848211024458.

PMID: 34262611 PMC: 8243104. DOI: 10.1177/17562848211024458.


A Phase 2 Randomized Trial of DCL-101, a Novel Pill-Based Colonoscopy Prep, vs 4L Polyethylene Glycol-Electrolyte Solution.

Bachwich D, Lewis J, Kowal V, Jacobson B, Calderwood A, Kochman M Clin Transl Gastroenterol. 2021; 11(12):e00264.

PMID: 33512795 PMC: 7678801. DOI: 10.14309/ctg.0000000000000264.


Pediatric bowel preparation: Sodium picosulfate, magnesium oxide, citric acid polyethylene glycol, a randomized trial.

Cuffari C, Ciciora S, Ando M, Boules M, Croffie J World J Gastroenterol. 2020; 26(40):6260-6269.

PMID: 33177798 PMC: 7596638. DOI: 10.3748/wjg.v26.i40.6260.


Efficacy, safety, and tolerability of a ready-to-drink bowel preparation in overweight and obese adults: subanalysis by body mass index from a phase III, assessor-blinded study.

Hookey L, Bertiger G, Johnson 2nd K, Boules M, Ando M, Dahdal D Therap Adv Gastroenterol. 2020; 13:1756284820910050.

PMID: 32313553 PMC: 7153178. DOI: 10.1177/1756284820910050.